Skip to main content
Erschienen in: Journal of Hematopathology 1/2016

01.03.2016 | Letter to the editor

Aggressive T-LGL or indolent Hepatosplenic T-cell lymphoma: case with a difficult differential diagnosis

verfasst von: Prabhjot Kaur

Erschienen in: Journal of Hematopathology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

T-cell large granular lymphocytic leukemia (T-LGL) is an indolent lymphoproliferative disorder characterized by persistent (>6 months) increase in peripheral blood immunophenotypically distinct, clonal population of large granular lymphocytes, usually between 2–20 × 10^9/L, without a clearly identifiable cause [1]. Hepatosplenic T-cell lymphoma (HSTL), on the other hand, is a uniformly aggressive disease with a fulminant systemic clinical presentation with massive hepatosplenomegaly, bone marrow involvement, thrombocytopenia and anemia, and B symptoms with survival counted in months (6–16 months) from the time of diagnosis [1]. More indolent variants are not recognized. This is a case with clinical presentation more compatible with T-large granular lymphocytic leukemia (T-LGL) and clinically followed as such, until it manifested clinically aggressively with B symptoms, splenomegaly, lymphadenopathy, and morphologically compatible with HSTL. This case continued to challenge us with the differential of a case of T-LGL with aggressive transformation or a HSTL with indolent presentation. …
Literatur
1.
Zurück zum Zitat WHO 2008: Gaulard P et al Hepatosplenic T cell lymphoma WHO 2008 292–293. WC Chan et al. T-cell large granular lymphocytic leukemia. WHO, 2008 Pages 272–275 WHO 2008: Gaulard P et al Hepatosplenic T cell lymphoma WHO 2008 292–293. WC Chan et al. T-cell large granular lymphocytic leukemia. WHO, 2008 Pages 272–275
2.
Zurück zum Zitat Morice WG, Kurtin PJ, Tefferi A, Hanson CA (2002) Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 99(1):268–74CrossRef Morice WG, Kurtin PJ, Tefferi A, Hanson CA (2002) Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 99(1):268–74CrossRef
3.
Zurück zum Zitat Morice WG, Kurtin PJ, Leibson PJ, Tefferi A, Hanson CA (2003) Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol 120(6):1026–36CrossRef Morice WG, Kurtin PJ, Leibson PJ, Tefferi A, Hanson CA (2003) Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol 120(6):1026–36CrossRef
4.
Zurück zum Zitat Sandberg Y, van Dongen JJ, Miguel JF, Orfao A, Langerak AW (2006) TCRgammadelta + large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta + T-cells. Leukemia 20(3):505–13CrossRef Sandberg Y, van Dongen JJ, Miguel JF, Orfao A, Langerak AW (2006) TCRgammadelta + large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta + T-cells. Leukemia 20(3):505–13CrossRef
5.
Zurück zum Zitat Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES (1996) Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gamma delta t-cell origin. Blood 88(11):4265–74PubMed Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES (1996) Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gamma delta t-cell origin. Blood 88(11):4265–74PubMed
6.
Zurück zum Zitat Vega F, Medeiros J, Gaulard P (2007) Hepatosplenic and other GD T cell lymphomas. Am J Clin Pathol 127:869–880CrossRef Vega F, Medeiros J, Gaulard P (2007) Hepatosplenic and other GD T cell lymphomas. Am J Clin Pathol 127:869–880CrossRef
7.
Zurück zum Zitat Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R, Deconinck E, Charlotte F, Leblond V, Labouyrie E, Lederlin P, Emile JF, Delmas-Marsalet B, Arnulf B, Zafrani ES, Gaulard P (2003) Hepatosplenic gamma/delta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102(13):4261–9CrossRef Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R, Deconinck E, Charlotte F, Leblond V, Labouyrie E, Lederlin P, Emile JF, Delmas-Marsalet B, Arnulf B, Zafrani ES, Gaulard P (2003) Hepatosplenic gamma/delta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102(13):4261–9CrossRef
8.
Zurück zum Zitat Vega F, Medeiros LJ, Bueso-Ramos C, Jones D, Lai R, Luthra R, Abruzzo LV (2001) Hepatosplenic gamma/delta t-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol 116(3):410–9CrossRef Vega F, Medeiros LJ, Bueso-Ramos C, Jones D, Lai R, Luthra R, Abruzzo LV (2001) Hepatosplenic gamma/delta t-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol 116(3):410–9CrossRef
9.
Zurück zum Zitat Epling-Burnette PK, Painter JS, Chaurasia P, Bai F, Wei S, Djeu JY, Loughran TP Jr (2004) Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 103(9):3431–9CrossRef Epling-Burnette PK, Painter JS, Chaurasia P, Bai F, Wei S, Djeu JY, Loughran TP Jr (2004) Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 103(9):3431–9CrossRef
10.
Zurück zum Zitat Macon WR M.D, Levy NB M.D, Kurtin PJ M.D, Cousar JB M.D (2001) Hepatosplenic [alpha][beta] T-Cell Lymphomas: a report of 14 cases and comparison with hepatosplenic [gamma][delta] T-cell lymphomas. Am J Surg Pathol 25(3):285–296CrossRef Macon WR M.D, Levy NB M.D, Kurtin PJ M.D, Cousar JB M.D (2001) Hepatosplenic [alpha][beta] T-Cell Lymphomas: a report of 14 cases and comparison with hepatosplenic [gamma][delta] T-cell lymphomas. Am J Surg Pathol 25(3):285–296CrossRef
11.
Zurück zum Zitat Gentile TC, Uner AH, Hutchison RE, Wright J, Ben-Ezra J, Russell EC, Loughran TP Jr (1994) CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood 84(7):2315–21PubMed Gentile TC, Uner AH, Hutchison RE, Wright J, Ben-Ezra J, Russell EC, Loughran TP Jr (1994) CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood 84(7):2315–21PubMed
12.
Zurück zum Zitat Alekshun TJ, Tao J, Sokol L (2007) Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature. Am J Hematol 82:481–485CrossRef Alekshun TJ, Tao J, Sokol L (2007) Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature. Am J Hematol 82:481–485CrossRef
13.
Zurück zum Zitat Macon WR, Williams ME, Greer JP et al (1996) Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 87:1474–1483PubMed Macon WR, Williams ME, Greer JP et al (1996) Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 87:1474–1483PubMed
14.
Zurück zum Zitat Matutes E, Wotherspoon AC, Parker NE et al (2001) Transformation of T-cell large granular lymphocyte leukemia into a high-grade large T-cell lymphoma. Br J Haematol 115:801–806CrossRef Matutes E, Wotherspoon AC, Parker NE et al (2001) Transformation of T-cell large granular lymphocyte leukemia into a high-grade large T-cell lymphoma. Br J Haematol 115:801–806CrossRef
15.
Zurück zum Zitat Gaulard P, Belhadj K, Reyes F (2003) Gammadelta T-cell lymphomas. Semin Hematol 40(3):233–43CrossRef Gaulard P, Belhadj K, Reyes F (2003) Gammadelta T-cell lymphomas. Semin Hematol 40(3):233–43CrossRef
16.
Zurück zum Zitat Bennett M, Matutes E, Gaulard P (2010) Hepatosplenic T cell lymphoma responsive to 2'-deoxycoformycin therapy. Am J Hematol 85(9):727–9CrossRef Bennett M, Matutes E, Gaulard P (2010) Hepatosplenic T cell lymphoma responsive to 2'-deoxycoformycin therapy. Am J Hematol 85(9):727–9CrossRef
Metadaten
Titel
Aggressive T-LGL or indolent Hepatosplenic T-cell lymphoma: case with a difficult differential diagnosis
verfasst von
Prabhjot Kaur
Publikationsdatum
01.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Hematopathology / Ausgabe 1/2016
Print ISSN: 1868-9256
Elektronische ISSN: 1865-5785
DOI
https://doi.org/10.1007/s12308-015-0265-0

Weitere Artikel der Ausgabe 1/2016

Journal of Hematopathology 1/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …